Correct Answer: D. Promethazine
Promethazine is a first-generation antihistamine with potent anticholinergic and sedative properties that make it highly effective for motion sickness. The mechanism of motion sickness involves activation of the chemoreceptor trigger zone and vestibular nuclei, which communicate with the vomiting centre via histamine and acetylcholine pathways. Promethazine blocks both H₁ receptors (antihistamine effect) and muscarinic receptors (anticholinergic effect), providing dual suppression of nausea and vomiting signals. Its lipophilic nature allows excellent CNS penetration, and the sedative side-effect actually enhances its antiemetic utility by reducing vestibular sensitivity. In Indian clinical practice, promethazine is the standard DOC for motion sickness, travel sickness, and post-operative nausea. It is typically given 30 minutes before travel at a dose of 12.5–25 mg orally or 25 mg IM/IV. The anticholinergic component is crucial—it reduces acetylcholine-mediated vestibular input to the vomiting centre, which is why pure antihistamines without anticholinergic activity are ineffective for motion sickness.
Why the other options are wrong
A. Misolastin — This is wrong because misolastin is not a recognized antiemetic or antihistamine drug in standard Indian pharmacology. It appears to be a distractor with a plausible-sounding name. NBE uses non-existent drug names to test whether students can distinguish real drugs from fabrications—a common trap in pharmacology MCQs. B. Loratidine — Loratidine (loratadine) is a second-generation antihistamine that is selective for H₁ receptors and lacks anticholinergic properties. While it is non-sedating and useful for allergic rhinitis, it has NO antiemetic or anti-motion-sickness activity. NBE pairs second-generation antihistamines with motion sickness to trap students who think 'antihistamine = antiemetic'—a critical misconception. C. Cetirizine — Cetirizine is a second-generation, non-sedating H₁-selective antihistamine used for allergies. Like loratadine, it lacks anticholinergic activity and CNS penetration, making it ineffective for motion sickness. The trap here is confusing antihistamines used for allergies with those used for antiemesis—only first-generation agents with anticholinergic properties work for motion sickness.
High-Yield Facts
- Promethazine is the gold-standard DOC for motion sickness due to dual H₁ and muscarinic antagonism.
- Second-generation antihistamines (loratadine, cetirizine, fexofenadine) are ineffective for motion sickness because they lack anticholinergic activity.
- Anticholinergic effect is the critical mechanism for motion sickness—it blocks acetylcholine-mediated vestibular signals to the vomiting centre.
- Promethazine dosing: 12.5–25 mg orally 30 minutes before travel; can also be given IM/IV for acute nausea.
- First-generation antihistamines (promethazine, chlorpromazine, diphenhydramine) are preferred for antiemesis; second-generation agents are preferred for allergies only.
Mnemonics
FIRST-GEN for MOTION First-generation antihistamines (Promethazine, Diphenhydramine, Chlorpromazine) = Motion sickness. Second-generation (Loratadine, Cetirizine) = Allergies only. Use when distinguishing antiemetic vs. anti-allergy agents. ACE = No Antiemesis Allergen-selective (second-gen) = Cetirizine, Effective for allergies only—NOT antiemesis. Helps reject loratadine and cetirizine in motion sickness questions.
NBE Trap
NBE pairs second-generation antihistamines (loratadine, cetirizine) with motion sickness to exploit the misconception that "all antihistamines treat nausea." The discriminator is anticholinergic activity—only first-generation agents have it, and only they work for motion sickness.
Clinical Pearl
In Indian outpatient practice, promethazine 25 mg IM is the rapid rescue for acute motion sickness or post-operative nausea in hospital settings. Patients often ask for "allergy medicine" for travel sickness—educating them that motion sickness requires anticholinergic agents, not modern antihistamines, is a key clinical teaching point.
_Reference: KD Tripathi Pharmacology Ch. 16 (Antihistamines & Autacoids); Harrison Ch. 34 (Nausea & Vomiting)_